Cited by 2,514Global Cancer Incidence and ScreeningBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology Studies

The DOI matches its Crossref record; 52 of the 55 references it cites were found in a registry or an index.

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

Antoni, Sebastien, Ferlay, Jacques, Soerjomataram, Isabelle, Znaor, Ariana, Jemal, Ahmedin, Bray, Freddie·2017·European Urology

DOI 10.1016/j.eururo.2016.06.010

Open this paper in CoChat — free account

Abstract

Context Bladder cancer has become a common cancer globally, with an estimated 430 000 new cases diagnosed in 2012. Objective We examine the most recent global bladder cancer incidence and mortality patterns and trends, the current understanding of the aetiology of the disease, and specific issues that may influence the registration and reporting of bladder cancer. Evidence acquisition Global bladder cancer incidence and mortality statistics are based on data from the International Agency for Research on Cancer and the World Health Organisation (Cancer Incidence in Five Continents, GLOBOCAN, and the World Health Organisation Mortality). Evidence synthesis Bladder cancer ranks as the ninth most frequently-diagnosed cancer worldwide, with the highest incidence rates observed in men in Southern and Western Europe, North America, as well in certain countries in Northern Africa or Western Asia. Incidence rates are consistently lower in women than men, although sex differences varied greatly between countries. Diverging incidence trends were also observed by sex in many countries, with stabilising or declining rates in men but some increasing trends seen for women. Bladder cancer ranks 13th in terms of deaths ranks, with mortality rates decreasing particularly in the most developed countries; the exceptions are countries undergoing rapid economic transition, including in Central and South America, some central, southern, and eastern European countries, and the Baltic countries. Conclusions The observed patterns and trends of bladder cancer incidence worldwide appear to reflect the prevalence of tobacco smoking, although infection with Schistosoma haematobium and other risk factors are major causes in selected populations. Differences in coding and registration practices need to be considered when comparing bladder cancer statistics geographically or over time. Patient summary The main risk factor for bladder cancer is tobacco smoking. The observed patterns and trends of bladder cancer incidence worldwide appear to reflect the prevalence of tobacco smoking.

Integrity signals

Registry

Crossref · 10.1016/j.eururo.2016.06.010

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Self-citation
Cancer Incidence in Five Continents
Doll, R., Muir, C. S., & Waterhouse, J. A. H. (1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,485
The United Nations Development Programme
Oestreich, J. E. (2017) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780190637347.003.0003 · Cited by 4,875
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
Babjuk, M. M., Andreas Böhle, E., Burger, M., Čapoun, O., Cohen, D. L., Compérat, É., Hernández, V., KAASINEN, E. S., Palou, J., Morgan Rouprêt, A., et al. (2016) · European Urology · doi:10.1016/j.eururo.2016.05.041 · Cited by 2,240
Epidemiology and Risk Factors of Urothelial Bladder Cancer
Burger, M., Catto, J. W. F., Dalbagni, G. M., Grossman, H. B., Herr, H. W., Karakiewicz, P. I., Kassouf, W., Kiemeney, L. A. L. M., Vecchia, C. L., Shariat, S. F., et al. (2012) · European Urology · doi:10.1016/j.eururo.2012.07.033 · Cited by 2,212
Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk
Steinmann, P., Keiser, J., Bos, R., Tanner, M., & Utzinger, J. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70521-7 · Cited by 2,146
Smoking prevalence and cigarette consumption in 187 countries, 1980-2012
Ng, M., Freeman, M. K., Fleming, T. D., Robinson, M., Dwyer-Lindgren, L., Thomson, B., Wollum, A., Sanman, E., Wulf, S., Lopez, A. D., et al. (2014) · JAMA · doi:10.1001/jama.2013.284692 · Cited by 1,576
Estimating average annual per cent change in trend analysis
Clegg, L. X., Hankey, B. F., Tiwari, R. C., Feuer, E. J., & Edwards, B. K. (2009) · Statistics in Medicine · doi:10.1002/sim.3733 · Cited by 1,271
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
Babjuk, M., Burger, M., Zigeuner, R., Shariat, S. F., van Rhijn, B. W. G., Compérat, E., Sylvester, R. J., Kaasinen, E., Böhle, A., Palou Redorta, J., et al. (2013) · European Urology · doi:10.1016/j.eururo.2013.06.003 · Cited by 1,174

Show all 55 references

Research works printed but not linked: 1

Loader C. Smoothing: Local Regression Techniques Web site. http://hdl.handle.net/10419/22186.

Sorted by citations

Items 501–600 of 1,000

Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer
Song, Y., Jin, D., Chen, J., Luo, Z., Chen, G., Yang, Y., & Liu, X. (2020) · Aging · doi:10.18632/aging.103369 · Cited by 29
MicroRNA‑34a‑5p serves as a tumor suppressor by regulating the cell motility of bladder cancer cells through matrix metalloproteinase‑2 silencing
Chou, K., Chang, A., Tsai, T., Lin, Y., Chen, H.-E., Ho, C., Chen, P., & Hwang, T. I. S. (2020) · Oncology Reports · doi:10.3892/or.2020.7910 · Cited by 29
A positive feedback loop between TAZ and miR-942-3p modulates proliferation, angiogenesis, epithelial-mesenchymal transition process, glycometabolism and ROS homeostasis in human bladder cancer
Wang, F., Fan, M., Zhou, X., Yu, Y., Cai, Y., Wu, H., Zhang, Y., Liu, J., Huang, S., He, N., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01846-5 · Cited by 29
Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors
Brown, J. T., Liu, Y., Shabto, J. M., Martini, D. J., Ravindranathan, D., Hitron, E., Russler, G. A., Caulfield, S. E., Yantorni, L. B., Joshi, S. S., et al. (2021) · The Oncologist · doi:10.1002/onco.13727 · Cited by 28
Biomarker-Oriented Therapy in Bladder and Renal Cancer
Scholtes, M., Alberts, A. R., Iflé, I. G., Verhagen, P. C. M. S., van der Veldt, A. A. M., & Zuiverloon, T. C. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062832 · Cited by 29
Putative markers for the detection of early-stage bladder cancer selected by urine metabolomics
Lin, J., Juo, B.-R., Yeh, Y.-H., Fu, S.-H., Chen, Y., Chen, C., & Wu, K. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04235-z · Cited by 29
CircRNA hsa_circ_0014130 Function as a miR-132-3p Sponge to Play an Oncogenic Role in Bladder Cancer Cells by Upregulating KCNJ12 Expression
Li, G., Guo, B., Wang, H., Lin, G.-T., Lan, T., Ying, H., & Xu, J. (2021) · Cell Biology and Toxicology · doi:10.1007/s10565-021-09668-z · Cited by 30
PDE4B Induces Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Is Transcriptionally Suppressed by CBX7
Huang, Z., Liu, J., Yang, J., Yan, Y., Yang, C., He, X. H., Huang, R., Tan, M., Wu, D., Yan, J., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.783050 · Cited by 29
Raman spectroscopy biochemical characterisation of bladder cancer cisplatin resistance regulated by FDFT1: a review
Kanmalar, M., Sani, S. F. A., Kamri, N. I. N. B., Said, N. A. B. M., Jamil, A. H. A., Kuppusamy, S., Mun, K.-S., & Bradley, D. A. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00307-x · Cited by 29
Preoperative Fibrinogen-to-Albumin Ratio as Potential Predictor of Bladder Cancer: A Monocentric Retrospective Study
Barone, B., Napolitano, L., Reccia, P., Luca, L. D., Morra, S., Turco, C., Melchionna, A., Caputo, V. F., Cirillo, L., Fusco, G. M., et al. (2022) · Medicina · doi:10.3390/medicina58101490 · Cited by 30
Decitabine augments cytotoxicity of cisplatin and doxorubicin to bladder cancer cells by activating hippo pathway through RASSF1A
Khandelwal, M., Anand, V., Appunni, S., Seth, A., Singh, P., Mathur, S. R., & Sharma, A. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3278-z · Cited by 29
RSPO3 promotes the aggressiveness of bladder cancer via Wnt/β-catenin and Hedgehog signaling pathways
Chen, Z., Zhou, L., Chen, L., Xiong, M., Kazobinka, G., Pang, Z., & Hou, T. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy140 · Cited by 31
Molecular characterization of low grade and high grade bladder cancer
Apollo, A., Ortenzi, V., Scatena, C., Zavaglia, K. M., Aretini, P., Lessi, F., Franceschi, S., Tomei, S., Sepich, C. A., Viacava, P., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210635 · Cited by 29
Disparities in Bladder Cancer Treatment and Survival Amongst Elderly Patients with a Pre-existing Mental Illness
Sathianathen, N. J., Fan, Y., Jarosek, S. L., Konety, I., Weight, C., Vinogradov, S., & Konety, B. R. (2019) · European Urology Focus · doi:10.1016/j.euf.2019.02.007 · Cited by 29
Assessing the Feasibility and Accuracy of High-resolution Microultrasound Imaging for Bladder Cancer Detection and Staging
Saita, A. R., Giovanni Lughezzani, A., Buffi, N. M., Hurle, R. F., Nava, L. D., Colombo, P., Diana, P., Fasulo, V., Paciotti, M., Elefante, G. M., et al. (2019) · European Urology · doi:10.1016/j.eururo.2019.03.044 · Cited by 29
Identification of immune-related genes as prognostic factors in bladder cancer
Zhu, J., Wang, H., Ma, T., He, Y. L., Shen, M., Song, W., Wang, J., Shi, J., Wu, M., Liu, C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-76688-w · Cited by 29
Proteogenomics of different urothelial bladder cancer stages reveals distinct molecular features for papillary cancer and carcinoma in situ
Yao, Z., Xu, N., Shang, G., Wang, H., Tao, H., Wang, Y., Qin, Z., Tan, S., Feng, J., Zhu, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41139-3 · Cited by 29
The Urinary Microbiome in Health and Disease: Relevance for Bladder Cancer
Kuštrimović, N. Z., Bilato, G., Mortara, L., & Baci, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031732 · Cited by 31
Extrachromosomal circular DNA orchestrates genome heterogeneity in urothelial bladder carcinoma
Lv, W., Pan, X., Han, P., Wu, S., Zeng, Y., Wang, Q., Guo, L., Xu, M., Wang, F., Qi, Y., et al. (2024) · Theranostics · doi:10.7150/thno.99563 · Cited by 28
Global, regional, and national burden of bladder cancer, 1990–2019: an age-period-cohort analysis based on the Global Burden of Disease 2019 study
Zhang, L., Wang, P., Wang, Y.-B., & He, Z.-Q. (2024) · Public Health · doi:10.1016/j.puhe.2024.07.027 · Cited by 28
Current concept of transurethral resection of bladder cancer
Schraml, J., Silva, J. D. C., & Babjuk, M. M. (2018) · Current Opinion in Urology · doi:10.1097/mou.0000000000000542 · Cited by 28
Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer?
Racioppi, M., Gianfrancesco, L. D., Ragonese, M., Palermo, G., Sacco, E., & Bassi, P. F. (2019) · International braz j urol · doi:10.1590/s1677-5538.ibju.2018.0249 · Cited by 28
Implementation of enhanced recovery after surgery in patients undergoing radical cystectomy: A retrospective cohort study.
Zhang, H., Wang, H.-H., Zhu, M.-M., Xu, Z., Shen, Y.-J., Zhu, Y.-P., Xu, Y.-J., Chen, W.-K., & Miao, C. (2020) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2019.07.021 · Cited by 26
Isoflurane promotes epithelial-to-mesenchymal transition and metastasis of bladder cancer cells through HIF-1α-β-catenin/Notch1 pathways
Lu, N., Piao, M., Feng, C., & Yuan, Y. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118154 · Cited by 28
α-E-Catenin (CTNNA1) Inhibits Cell Proliferation, Invasion and EMT of Bladder Cancer
Chi, Q., Xu, H., Song, D., Wang, Z., Wang, Z., & Ma, G. (2020) · Cancer Management and Research · doi:10.2147/cmar.s259269 · Cited by 28
Application of bi-planar reduced field-of-view DWI (rFOV DWI) in the assessment of muscle-invasiveness of bladder cancer
Meng, X., Hu, H., Wang, Y., Hu, D., Li, Z., & Feng, C. (2020) · European Journal of Radiology · doi:10.1016/j.ejrad.2020.109486 · Cited by 28
Molecular markers of systemic therapy response in urothelial carcinoma
Claps, F., Mir, M. C., & Zargar, H. S. (2021) · Asian journal of urology · doi:10.1016/j.ajur.2021.05.001 · Cited by 28
Antimony exposure promotes bladder tumor cell growth by inhibiting PINK1-Parkin-mediated mitophagy
Lou, Y., Ma, C., Liu, Z., Shi, J., Zheng, G., Zhang, C., & Zhang, Z. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.112420 · Cited by 28
SUMOylation Pattern Predicts Prognosis and Indicates Tumor Microenvironment Infiltration Characterization in Bladder Cancer
Xia, Q., Sun, J., Xun, Y., Xiao, J., Liu, C., Xu, J., An, Y., Xu, M., Liu, Z., Wang, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.864156 · Cited by 28
miR‐221/222 cluster expression improves clinical stratification of non‐muscle invasive bladder cancer (TaT1) patients' risk for short‐term relapse and progression
Tsikrika, F. D., Avgeris, M., Levis, P. K., Tokas, T., STRAVODIMOS, K. G., & Scorilas, A. (2017) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22516 · Cited by 28
TACC3 transcriptionally upregulates E2F1 to promote cell growth and confer sensitivity to cisplatin in bladder cancer
Lin, Z.-R., Wang, M.-Y., He, S., Cai, Z., & Huang, W. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0112-6 · Cited by 28
MicroRNA‐133b suppresses bladder cancer malignancy by targeting TAGLN2‐mediated cell cycle
Zhao, F., Zhou, L., Ge, Y., Ping, W., Wu, X., Xu, Z., Wang, M., Sha, Z., & Jia, R. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27288 · Cited by 28
Bladder Preservation Therapy: Review of Literature and Future Directions of Trimodal Therapy
El‐Achkar, A., Souhami, L., & Kassouf, W. (2018) · Current Urology Reports · doi:10.1007/s11934-018-0859-z · Cited by 28
Patients' perspective on digital technologies in advanced genitourinary cancers
Rodler, S., Buchner, A., Stief, C. G., Heinemann, V., Staehler, M., & Casuscelli, J. (2021) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2020.03.018 · Cited by 27
Targeting fibroblast growth factor receptors and immune checkpoint inhibitors for the treatment of advanced bladder cancer: New direction and New Hope
Morales‐Barrera, R., Suárez, C., de Castro, A. M. M., Racca, F., Valverde, C. M., Maldonado, X., Bastaros, J. M., Moróte, J., & Carles, J. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.09.018 · Cited by 26
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non–muscle-invasive Bladder Cancer
Racioppi, M., Gianfrancesco, L. D., Ragonese, M., Palermo, G., Sacco, E., & Bassi, P. (2018) · European Urology Oncology · doi:10.1016/j.euo.2018.08.032 · Cited by 27
New Insights in Bladder Cancer Diagnosis: Urinary miRNAs and Proteins
Amuran, G. G., Eyüboğlu, İ. P., Tınay, İ., & Akkіprіk, M. (2018) · Medical Sciences · doi:10.3390/medsci6040113 · Cited by 27
Analysis of the role of mutations in the KMT 2D histone lysine methyltransferase in bladder cancer
Ding, B., Yan, L., Zhang, Y., Wang, Z., Zhang, Y., Ding, X., Ye, Z., & Xu, H. (2019) · FEBS Open Bio · doi:10.1002/2211-5463.12600 · Cited by 27
ciRs-6 upregulates March1 to suppress bladder cancer growth by sponging miR-653
Su, Y., Feng, W., Zhong, G., Ya, Y., Du, Z., Shi, J., Chen, L., Dong, W., & Lin, T. (2019) · Aging · doi:10.18632/aging.102525 · Cited by 27
Coffee consumption and risk of bladder cancer: a pooled analysis of 501,604 participants from 12 cohort studies in the BLadder Cancer Epidemiology and Nutritional Determinants (BLEND) international study
Yu, E. Y.-W., Dai, Y., Wesselius, A., van Osch, F., Brinkman, M. T., van den Brandt, P. A., Grant, E. J., White, E., Weiderpass, E., Gunter, M. J., et al. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-019-00597-0 · Cited by 27
Liquid Biopsies to Select Patients for Perioperative Chemotherapy in Muscle-invasive Bladder Cancer: A Systematic Review
de Kruijff, I. E., Beije, N., Martens, J. W. M., de Wit, R., Boormans, J. L., & Sleijfer, S. (2020) · European Urology Oncology · doi:10.1016/j.euo.2020.01.003 · Cited by 27
Current updates on the role of reactive oxygen species in bladder cancer pathogenesis and therapeutics
Liu, D., Qiu, X., Xiong, X., Chen, X., & Pan, F. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-020-02330-w · Cited by 27
Gene Expression Profiles Identified Novel Urine Biomarkers for Diagnosis and Prognosis of High-Grade Bladder Urothelial Carcinoma
Song, Y., Jin, D., Ou, N., Luo, Z., Chen, G., Chen, J., Yang, Y., & Liu, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00394 · Cited by 27
Preoperative frailty and outcome in patients undergoing radical cystectomy
van der Vlies, E., Los, M., Stijns, P. E. F., van Hengel, M., Blaauw, N. M. S., Bos, W. J. W., van Dongen, E. P. A., van Melick, H. H. E., & Noordzij, P. G. (2020) · British Journal of Urology · doi:10.1111/bju.15132 · Cited by 27
Silencing of miR-152 contributes to DNMT1-mediated CpG methylation of the PTEN promoter in bladder cancer
Liu, P., Wu, L., Chand, H., Li, C., Hu, X., & Li, Y. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118311 · Cited by 27
The role of URO17™ biomarker to enhance diagnosis of urothelial cancer in new hematuria patients—First European Data
Vasdev, N., Hampson, A., Agarwal, S., Swamy, R., Chilvers, M., Hampson, A., Jahanfard, S., & Kim, N. (2020) · BJUI Compass · doi:10.1002/bco2.50 · Cited by 27
LINC01451 drives epithelial-mesenchymal transition and progression in bladder cancer cells via LIN28/TGF-β/Smad pathway
Shi, H., Xie, J., Wang, K., Li, W., Yin, L., Wang, G., Wu, Z., Ni, J., Mao, W., Guo, C., et al. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.109932 · Cited by 27
Combining volumetric apparent diffusion coefficient histogram analysis with vesical imaging reporting and data system to predict the muscle invasion of bladder cancer
Li, S., Liang, P., Wang, Y., Feng, C., Shen, Y., Hu, X., Hu, D., Meng, X., & Li, Z. (2021) · Abdominal Radiology · doi:10.1007/s00261-021-03091-y · Cited by 27
Preliminary Exploration of the Application of Vesical Imaging‐Reporting and Data System ( VI‐RADS ) in Post‐treatment Patients With Bladder Cancer: A Prospective Single‐Center Study
Cao, B., Li, Q., Xu, P., Chen, W., Hu, X., Dai, C., Shan, Y., Ding, Y., Mao, W., Liu, K., et al. (2021) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27807 · Cited by 27
Integrative Transcriptome Profiling Reveals SKA3 as a Novel Prognostic Marker in Non-Muscle Invasive Bladder Cancer
You, C., Piao, X., Kang, K., Kim, Y., & Kang, K. (2021) · Cancers · doi:10.3390/cancers13184673 · Cited by 27
LncRNA TUG1 promotes bladder cancer malignant behaviors by regulating the miR-320a/FOXQ1 axis
Tan, J., Liu, B., Zhou, L., Gao, J., Wang, X., Liu, Y., & Wang, J. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110216 · Cited by 27
Treatment trends for muscle-invasive bladder cancer in Germany from 2006 to 2019
Flegar, L., Kraywinkel, K., Zacharis, A., Aksoy, C., Koch, R., Eisenmenger, N., Groeben, C., & Huber, J. C. (2022) · World Journal of Urology · doi:10.1007/s00345-022-04017-z · Cited by 27
Bladder cancer-associated microbiota: Recent advances and future perspectives
Zhang, W., Yang, F., Mao, S., Wang, R., Chen, H., Ran, Y., Liu, S., Wu, P., Yan, Y., Li, W., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13012 · Cited by 27
Prognostic role of N-cadherin expression in patients with non–muscle-invasive bladder cancer
Abufaraj, M. M., Shariat, S. F., Haitel, A., Moschini, M., Foerster, B., Chłosta, P. L., Gust, K. M., Babjuk, M., Briganti, A., Karakiewicz, P. I., et al. (2017) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2017.01.012 · Cited by 27
Prognostic Impact of Canonical TGF-β Signaling in Urothelial Bladder Cancer
Stojnev, S., Krstić, M., Kokoris, J. Č., Conić, I., Petković, I., Ilić, S., Milošević, J., & Veličković, L. J. (2019) · Medicina · doi:10.3390/medicina55060302 · Cited by 27
Bladder cancer trends and mortality in the brazilian public health system
Timóteo, F., Korkes, F., Baccaglini, W. R. C., & Glina, S. (2020) · International braz j urol · doi:10.1590/s1677-5538.ibju.2019.0198 · Cited by 27
Preoperative CT-based deep learning radiomics model to predict lymph node metastasis and patient prognosis in bladder cancer: a two-center study
Sun, R., Zhang, M., Yang, L., Yang, S., Li, N., Huang, Y., Song, H., Wang, B., Huang, C., Hou, F., et al. (2024) · Insights into Imaging · doi:10.1186/s13244-023-01569-5 · Cited by 26
Lactylation as a metabolic epigenetic modification: Mechanistic insights and regulatory pathways from cells to organs and diseases
Chen, C., Wang, J., Zhu, X., Zhang, S., Yuan, X., Hu, J., Liu, C., Liu, L., Zhang, Z., & Li, J. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156289 · Cited by 31
Monopolar vs. bipolar transurethral resection for non–muscle invasive bladder carcinoma: A post-hoc analysis from a randomized controlled trial
Liem, E. I. M. L., McCormack, M., Chan, E., Matsui, Y., Geavlete, P. A., Choi, Y. D., de Reijke, T. M., Farahat, Y., Inman, B. A., de la Rosette, J. J. M. C. H., et al. (2018) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2018.03.015 · Cited by 26
The interplay between adipose-derived stem cells and bladder cancer cells
Maj, M., Kokocha, A., Bajek, A., & Drewa, T. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-33397-9 · Cited by 26
Dihydrotestosterone increases the risk of bladder cancer in men
Gil, D., Zarzycka, M., Dulińska-Litewka, J., Ciołczyk-Wierzbicka, D., Lekka, M., & Laidler, P. M. (2019) · Human Cell · doi:10.1007/s13577-019-00255-3 · Cited by 26
The prognostic impact of GSTM1/GSTP1 genetic variants in bladder Cancer
Albarakati, N., Khayyat, D., Dallol, A., Al-Maghrabi, J. A., & Nedjadi, T. (2019) · BMC Cancer · doi:10.1186/s12885-019-6244-6 · Cited by 26
Coffee in cancer chemoprevention: an updated review
Ismail, T., Zeppa, S. D., Akhtar, S., Turrini, E., Layla, A., Sestili, P., & Fimognari, C. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1839412 · Cited by 27
Super-Enhancer LncRNA LINC00162 Promotes Progression of Bladder Cancer
Wang, X., Zhang, R., Wu, S., Shen, L., Ke, M., Ouyang, Y., Lin, M., Lyu, Y., Sun, B., Zheng, Z., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101857 · Cited by 26
Pathogenic mechanisms and the potential clinical value of circFoxo3 in cancers
Zhang, L., Wang, Y., Zhang, Y., Zhao, Y., & Li, P. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.01.010 · Cited by 26
Inhibition of Androgen Signalling Improves the Outcomes of Therapies for Bladder Cancer: Results from a Systematic Review of Preclinical and Clinical Evidence and Meta-Analysis of Clinical Studies
Creta, M., Celentano, G., Napolitano, L., Rocca, R. L., Capece, M., Califano, G., Ruvolo, C. C., Mangiapia, F., Morra, S., Turco, C., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11020351 · Cited by 26
Intra-arterial infusion chemotherapy utilizing cisplatin inhibits bladder cancer by decreasing the ﬁbrocytic myeloid-derived suppressor cells in an m6A-dependent manner
Mu, X., Wu, K., Zhu, Y., Zhu, Y., Wang, Y., Xiao, L., Yao, Z., Huang, W., Sun, F., Fan, J., et al. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.06.012 · Cited by 26
The efficacy and reliability of VI‐RADS in determining candidates for repeated transurethral resection in patients with high‐risk non‐muscle invasive bladder cancer
Erkoç, M., Ötünçtemur, A., Bozkurt, M., Can, O., Atalay, H. A., Beşiroğlu, H., Danış, E., & Değirmentepe, R. B. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14584 · Cited by 26
Circular RNA TAF4B Promotes Bladder Cancer Progression by Sponging miR-1298-5p and Regulating TGFA Expression
Zhang, X., Li, X., Fu, X., Yu, M., Qin, G., Chen, G., & Huang, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.643362 · Cited by 26
Glucose/Glutathione Co-triggered Tumor Hypoxia Relief and Chemodynamic Therapy to Enhance Photothermal Therapy in Bladder Cancer
Chen, W.-H., Yu, K., Jhou, J.-W., Pang, H., Weng, W., Lin, W.-S., & Yang, H. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c00741 · Cited by 26
IGFBP7 and the Tumor Immune Landscape: A Novel Target for Immunotherapy in Bladder Cancer
Yi, X., Zheng, X. S., Xu, H., Li, J., Zhang, T., Ge, P., Liao, D., Li, H., Lyu, X., & Ai, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.898493 · Cited by 26
PHB promotes bladder cancer cell epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway
Jiang, L., Guo, S., Huang, Z.-Y., Li, X.-L., Jin, X., Huang, W., & Tian, X. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154536 · Cited by 26
Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: Data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancer
Dowell, A. C., Cobby, E., Wen, K., Devall, A., During, V., Anderson, J., James, N. D., Cheng, K. K., Zeegers, M. P., Bryan, R. T., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184841 · Cited by 29
Estimating the impact of body mass index on bladder cancer risk: Stratification by smoking status
Choi, J. B., Lee, E. J., Han, K., Hong, S., & Ha, U. (2018) · Scientific Reports · doi:10.1038/s41598-018-19531-7 · Cited by 26
Nesfatin-1/Nucleobindin-2 Is a Potent Prognostic Marker and Enhances Cell Proliferation, Migration, and Invasion in Bladder Cancer
Liu, G.-M., Xu, Z., & Ma, H. (2018) · Disease Markers · doi:10.1155/2018/4272064 · Cited by 26
Retracted
Strategies for managing multi-patient 3D mass spectrometry imaging data
Vos, D. R. N., Jansen, I., Lucas, M., Paine, M. R. L., de Boer, O. J., Meijer, S. L., Savci-Heijink, C. D., Marquering, H. A., de Bruin, D. M., Heeren, R. M. A., et al. (2018) · Journal of Proteomics · doi:10.1016/j.jprot.2018.10.008 · Cited by 26
Gelsolin-like actin-capping protein has prognostic value and promotes tumorigenesis and epithelial-mesenchymal transition via the Hippo signaling pathway in human bladder cancer
Lyu, Z., Liu, Y., Chen, M., Yacun, C., Wu, S., He, A., Xinhui, L., Zhang, M., Wu, P., Mei, H., et al. (2019) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835919841235 · Cited by 26
MiR-362-5p, Which Is Regulated by Long Non-Coding RNA MBNL1-AS1, Promotes the Cell Proliferation and Tumor Growth of Bladder Cancer by Targeting QKI
Wei, X., Wang, B., Wang, Q., Yang, X., Yang, Y., Fang, Z., Yi, C., Shi, L., Fan, X., Tao, J., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00164 · Cited by 26
Urine Endocannabinoids as Novel Non-Invasive Biomarkers for Bladder Cancer at Early Stage
Vago, R., Ravelli, A., Bettiga, A., Casati, S., Lavorgna, G., Benigni, F., Salonia, A., Montorsi, F., Orioli, M., Ciuffreda, P., et al. (2020) · Cancers · doi:10.3390/cancers12040870 · Cited by 26
Hsa_circ_0068307 mediates bladder cancer stem cell-like properties via miR-147/c-Myc axis regulation
Chen, Q., Yin, Q., Mao, Y., Zhang, Z., Wu, S., Cheng, Z., Chen, X., Xu, H., Jin, S., Jiang, H., et al. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01235-6 · Cited by 26
Asparagine drives immune evasion in bladder cancer via RIG-I stability and type I IFN signaling
Wei, W., Li, H., Tian, S., Zhang, C., Liu, J., Tao, W., Cai, T., Dong, Y., Wang, C., Lu, D., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci186648 · Cited by 25
Fluid Shear Stress Induces Cell Cycle Arrest in Human Urinary Bladder Transitional Cell Carcinoma Through Bone Morphogenetic Protein Receptor-Smad1/5 Pathway
Lee, Y., Lai, C., & Cheng, Y. (2018) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-018-0523-1 · Cited by 25
Intravesical Radiofrequency-Induced Chemohyperthermia for Carcinoma in Situ of the Urinary Bladder: A Retrospective Multicentre Study
van Valenberg, F. J. P., Kajtazovic, A., Canepa, G., Lüdecke, G., Kilb, J.-I., Aben, K. K. H., Nativ, O., Madaan, S., Ayres, B. E., Issa, R., et al. (2018) · Bladder Cancer · doi:10.3233/blc-180187 · Cited by 25
Durvalumab for the management of urothelial carcinoma: a short review on the emerging data and therapeutic potential
Baldini, C., Champiat, S., Vuagnat, P., & Massard, C. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s141040 · Cited by 24
Effect of Ostomy Care Team Intervention on Patients With Ileal Conduit
Zhou, H., Ye, Y., Qu, H., Zhou, H., Gu, S., & Wang, T. (2019) · Journal of Wound Ostomy and Continence Nursing · doi:10.1097/won.0000000000000574 · Cited by 25
Safety and Short-Term Oncological Outcomes of Thulium Fiber Laser En Bloc Resection of Non-Muscle-Invasive Bladder Cancer: A Prospective Non-Randomized Phase II Trial
Enikeev, D. V., Taratkin, M. S., Margulis, V., Sorokin, N. I., Severgina, L., Paramonova, N. B., Kislyakov, D., Козлов, В. В., Rapoport, L. M., Shariat, S. F., et al. (2020) · Bladder Cancer · doi:10.3233/blc-200275 · Cited by 25
The circ_0004463/miR-380-3p/FOXO1 axis modulates mitochondrial respiration and bladder cancer cell apoptosis
Wu, S., Deng, H., He, H., Xu, R., Wang, Y., Zhu, X., Zhang, J., Zeng, Q., & Zhao, X. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1852746 · Cited by 25
Pegylated Recombinant Human Arginase 1 Induces Autophagy and Apoptosis via the ROS‐Activated AKT/mTOR Pathway in Bladder Cancer Cells
Zhao, Z., Zhang, P., Li, W., Wang, D., Ke, C., Liu, Y., Ho, J., Cheng, P. N.-M., & Xu, S. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5510663 · Cited by 25
CALD1 promotes the expression of PD-L1 in bladder cancer via the JAK/STAT signaling pathway
Li, C., Yang, F., Wang, R., Li, W., Maskey, N., Zhang, W., Guo, Y., Liu, S., Wang, H., & Yao, X. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-4192 · Cited by 26
The potential role of c-MYC and polyamine metabolism in multiple drug resistance in bladder cancer investigated by metabonomics
Zhu, Y., Piao, C., Zhang, Z., Jiang, Y., & Kong, C. (2021) · Genomics · doi:10.1016/j.ygeno.2021.11.028 · Cited by 25
Treatment of bladder cancer by geoinspired synthetic chrysotile nanocarrier-delivered circPRMT5 siRNA
Yu, C., Zhang, Y., Wang, N., Wei, W., Cao, K., Zhang, Q., Ma, P., Xie, D., Wu, P.-H., Liu, B., et al. (2022) · Biomaterials Research · doi:10.1186/s40824-022-00251-z · Cited by 25
Disinfection By-Products in Drinking Water and Bladder Cancer: Evaluation of Risk Modification by Common Genetic Polymorphisms in Two Case–Control Studies
Freeman, L. E. B., Kogevinas, M., Cantor, K. P., Villanueva, C. M., Prokunina‐Olsson, L., Flórez-Vargas, O., Figueroa, J. D., Ward, M. H., Koutros, S., Baris, D., et al. (2022) · Environmental Health Perspectives · doi:10.1289/ehp9895 · Cited by 25
TROP2 translation mediated by dual m6A/m7G RNA modifications promotes bladder cancer development
Chen, C., Chao, Y., Zhang, C., Hu, W., Huang, Y., Lv, Y., Liu, B., Ji, D., Liu, M., Yang, B., et al. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216246 · Cited by 25
N6-methyladenosine-modified CircPSMA7 enhances bladder cancer malignancy through the miR-128–3p/MAPK1 axis
Yi, J., Ma, X., Ying, Y., Liu, Z., Tang, Y., Shu, X., Sun, J., Wu, Y., Lu, D., Wang, X., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216613 · Cited by 25
Essentials of bladder cancer worldwide: incidence, mortality rate and risk factors
Gandomani, H. S., Tarazoj, A. A., Siri, F. H., Rozveh, A. K., Hosseini, S., Borujeni, N. N., Mohammadian-Hafshejani, A., & Salehiniya, H. (2017) · Biomedical Research and Therapy · doi:10.15419/bmrat.v4i9.371 · Cited by 25
Quality of Life in Patients with Bladder Cancer Undergoing Ileal Conduit: A Comparison of Women Versus Men
Siracusano, S., D’Elia, C., Cerruto, M. A., SALEH, O., Serni, S., Gacci, M., Ciciliato, S., Simonato, A., Porcaro, A. B., MARCO, V. D., et al. (2018) · In Vivo · doi:10.21873/invivo.11216 · Cited by 25
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer
Ferro, M., Mauro, M. D., Cimino, S., Morgia, G., Lucarelli, G. T., Farhan, A. R. A., Vartolomei, M. D., Porreca, A., Cantiello, F., Damiano, R., et al. (2021) · Translational Andrology and Urology · doi:10.21037/tau-20-1272 · Cited by 25
Intravesical radiofrequency induced hyperthermia enhances mitomycin C accumulation in tumour tissue
van Valenberg, F. J. P., van der Heijden, A. G., Lammers, R. J. M., Falke, J., Arends, T. J. H., Oosterwijk, E., & Witjes, J. A. (2017) · International Journal of Hyperthermia · doi:10.1080/02656736.2017.1406618 · Cited by 24
RETRACTED: Baicalein inhibits proliferation and migration of bladder cancer cell line T24 by down-regulation of microRNA-106
Jiang, L., Song, H., Guo, H., Wang, C., & Lu, Z.-P. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.107 · Cited by 24
Retracted
SWI/SNF chromatin remodeling complex and glucose metabolism are deregulated in advanced bladder cancer
Stachowiak, M., Szymanski, M., Ornoch, A., Jancewicz, I., Rusetska, N., Chrzan, A., Demkow, T., SIEDLECKI, J. A., Sarnowski, T. J., & Sarnowska, E. A. (2020) · IUBMB Life · doi:10.1002/iub.2254 · Cited by 24

Authors: Antoni, S., Ferlay, J., Soerjomataram, I., Znaor, A., Jemal, A., & Bray, F.
Affiliations: Centre international de recherche sur le cancer (FR)
American Cancer Society (US)
Corresponding author: Bray, Freddie
ORCID: Ferlay, Jacques
Soerjomataram, Isabelle
Znaor, Ariana
Jemal, Ahmedin
Bray, Freddie
Venue: European Urology
Publisher: Elsevier BV
Published: 2017-01
Volume: 71
Issue: 1
Pages: 96-108
ISSN: 0302-2838 (ISSN-L)
DOI: 10.1016/j.eururo.2016.06.010
OpenAlex: W2473162054
Cited by: 2,514
References: 55
Citations by year: 2026: 79 · 2025: 165 · 2024: 248 · 2023: 244 · 2022: 314 · 2021: 414 · 2020: 400 · 2019: 306 · 2018: 225 · 2017: 102
FWCI: 21.58
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: European Urology (publishedVersion)
PubMed (publishedVersion)
Funders: World Health Organization
Topics: Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Health Sciences › Medicine › Surgery › Bladder and Urothelial Cancer Treatments
Health Sciences › Medicine › Surgery › Urinary and Genital Oncology Studies
Keywords: bladder cancer, cancer incidence, cancer mortality, incidence trends, sex differences, smoking, Schistosoma haematobium, etiology, global cancer statistics
MeSH terms: Urinary Bladder Neoplasms, Female, Humans, Male, Registries, Risk Factors, Smoking, Global Health, Incidence, Internationality

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks